Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Succinylated gelatin versus normal saline for EMR of large sessile colonic polyps
ACTRN12609000939291Phase 3Completed
- Sponsor
- Dr Alan Moss and Dr Michael Bourke
- Start
- Apr 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gelofusine + sodium chloride and Normal Saline-Benha University in colonic polyp (2 arms), sponsored by Dr Alan Moss and Dr Michael Bourke. Primary endpoint: Ratio of lesion size to number of snare resection pieces. Started Apr 2009; status: completed.
02
Drugs
gelofusine + sodium chlorideNormal Saline-Benha University
03
Conditions
colonic polyp
Beyond the preview
Go deeper on ACTRN12609000939291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000939291.